- Home
- UPWK vs TARS Comparison
UPWK vs TARS Comparison
Compare UPWK & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UPWK
- TARS
- Stock Information
- Founded
- UPWK 2013
- TARS 2016
- Country
- UPWK United States
- TARS United States
- Employees
- UPWK N/A
- TARS N/A
- Industry
- UPWK EDP Services
- TARS Medicinal Chemicals and Botanical Products
- Sector
- UPWK Technology
- TARS Health Care
- Exchange
- UPWK Nasdaq
- TARS Nasdaq
- Market Cap
- UPWK 2.0B
- TARS 1.8B
- IPO Year
- UPWK 2018
- TARS 2020
- Fundamental
- Price
- UPWK $17.04
- TARS $53.26
- Analyst Decision
- UPWK Strong Buy
- TARS Strong Buy
- Analyst Count
- UPWK 11
- TARS 5
- Target Price
- UPWK $18.36
- TARS $54.20
- AVG Volume (30 Days)
- UPWK 1.9M
- TARS 469.2K
- Earning Date
- UPWK 11-06-2024
- TARS 11-13-2024
- Dividend Yield
- UPWK N/A
- TARS N/A
- EPS Growth
- UPWK N/A
- TARS N/A
- EPS
- UPWK 0.62
- TARS N/A
- Revenue
- UPWK $761,776,000.00
- TARS $129,621,000.00
- Revenue This Year
- UPWK $12.12
- TARS $895.24
- Revenue Next Year
- UPWK $3.41
- TARS $73.78
- P/E Ratio
- UPWK $27.44
- TARS N/A
- Revenue Growth
- UPWK 14.27
- TARS 801.96
- 52 Week Low
- UPWK $8.43
- TARS $18.84
- 52 Week High
- UPWK $17.79
- TARS $54.44
- Technical
- Relative Strength Index (RSI)
- UPWK 62.43
- TARS 64.67
- Support Level
- UPWK $16.56
- TARS $48.45
- Resistance Level
- UPWK $17.59
- TARS $53.85
- Average True Range (ATR)
- UPWK 0.46
- TARS 2.40
- MACD
- UPWK -0.17
- TARS -0.14
- Stochastic Oscillator
- UPWK 45.61
- TARS 80.30
About UPWK Upwork Inc.
Upwork Inc is a United States-based company that operates an online marketplace that enables businesses to find and work with skilled independent professionals. The company develops platform for hiring and freelancing purposes. Its products offering include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The business generates revenue from Talent and Clients across the USA, India, the Philippines and the rest of the world. Substantial income is derived from providing services to clients.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.